BIT Biotech Opportunities R-II
WKN A3DCBB | ISIN DE000A3DCBB8 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | LU2441282626 | Janus Henderson Horizon Biotechnology Fund IU2 EUR | +16,03 % | +20,60 % | 0,65 |
|
| 2 | IE00B3WVRB16 | Polar Capital Funds plc - Biotechnology Fund Class I EUR Distribution Shares | +15,18 % | +20,06 % | 0,63 |
|
| 3 | LU2441282899 | Janus Henderson Horizon Biotechnology Fund A2 EUR | +15,59 % | +20,81 % | 0,62 |
|
| 4 | LU1725387622 | Bellevue Funds (Lux) - Bellevue Obesity Solutions I2 EUR - Accumulating | +8,77 % | +10,69 % | 0,57 |
|
| 5 | LU0415392678 | Bellevue Funds (Lux) - Bellevue Obesity Solutions I EUR - Accumulating | +8,63 % | +10,69 % | 0,56 |
|
| 72 | DE000A3DCBA0 | BIT Biotech Opportunities I-II | -6,06 % | +32,43 % | -0,27 |
|
| 73 | LU0843168732 | Pictet - Biotech - HP CHF | -4,48 % | +22,89 % | -0,32 |
|
| 74 | LU2208649280 | UBS(Lux)E.F.-Biotech(USD)QL a.USD | -8,21 % | +19,31 % | -0,57 |
|
| 75 | LU0400035332 | UBS(Lux)E.F.-Biotech(USD)Q a.USD | -8,39 % | +19,32 % | -0,58 |
|
| 76 | LU0069152568 | UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD | -9,31 % | +19,31 % | -0,63 |
|